Aims and Scope of ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters is a peer-reviewed academic journal in the field of medicinal chemistry. Founded in 2009, this online journal is published monthly by the American Chemical Society. The Editor-in-Chief is Dennis C. Liotta (Emory University, Atlanta, Georgia, USA). Less
Key Metrics
CiteScore 

6.6
Eigenfactor 

0.01 - 0.05
Impact Factor 

< 5
SJR 

Q2Biochemistry

SNIP 

0.93
Recommended pre-submission checks
Powered by 

Topics Covered on ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | AMER CHEMICAL SOC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in ACS Medicinal Chemistry Letters ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in ACS Medicinal Chemistry Letters
Structure–Activity Relationship Analysis of Macrocyclic Peptide RAS Inhibitors: Spotlight on the Solvent-Exposed Region
- 12 May 2026
- ACS Medicinal Chemistry Letters
Computer-Aided Design of <i>Plasmodium chabaudi</i> -Derived Peptides with Dual Antibiofilm and Anti-inflammatory Activities
- 5 May 2026
- ACS Medicinal Chemistry Letters
Synthesis and Evaluation of Sulfobacin A and Analogues for Their Roles in Immunological Recognition
- 4 May 2026
- ACS Medicinal Chemistry Letters
In Vitro Characterization of Agonist and Antagonist Peptide Binding Interaction Kinetics to GLP-1R in HEK293T Cells Using Surface Plasmon Resonance Microscopy
- 3 May 2026
- ACS Medicinal Chemistry Letters
Design, Synthesis, and Protective Activity against Doxorubicin-Induced Cardiotoxicity of Novel Water-Soluble Small-Molecule GPx Mimics
- 24 Apr 2026
- ACS Medicinal Chemistry Letters
Discovery of MK-5661, a Once-Daily Oral Na <sub>V</sub> 1.8 Inhibitor for the Treatment of Pain
- 24 Apr 2026
- ACS Medicinal Chemistry Letters
Structure–Activity Relationship Analysis of Macrocyclic Peptide RAS Inhibitors: Spotlight on the Solvent-Exposed Region
- 12 May 2026
- ACS Medicinal Chemistry Letters
Computer-Aided Design of <i>Plasmodium chabaudi</i> -Derived Peptides with Dual Antibiofilm and Anti-inflammatory Activities
- 5 May 2026
- ACS Medicinal Chemistry Letters
Synthesis and Evaluation of Sulfobacin A and Analogues for Their Roles in Immunological Recognition
- 4 May 2026
- ACS Medicinal Chemistry Letters
In Vitro Characterization of Agonist and Antagonist Peptide Binding Interaction Kinetics to GLP-1R in HEK293T Cells Using Surface Plasmon Resonance Microscopy
- 3 May 2026
- ACS Medicinal Chemistry Letters
Design, Synthesis, and Protective Activity against Doxorubicin-Induced Cardiotoxicity of Novel Water-Soluble Small-Molecule GPx Mimics
- 24 Apr 2026
- ACS Medicinal Chemistry Letters
Discovery of MK-5661, a Once-Daily Oral Na <sub>V</sub> 1.8 Inhibitor for the Treatment of Pain
- 24 Apr 2026
- ACS Medicinal Chemistry Letters